Text size :

Feletti (UniVr): “Early diagnosis and surveillance to prevent Vhl damage”

ADNKRONOS

November 11, 2026

Rome, Nov 11. (Adnkronos Health) – “Von Hippel-Lindau disease is a hereditary genetic pathology that predisposes to the formation of neoplasms in various organs. Symptoms depend on the location of the lesions, which can affect the central nervous system, retina, hearing, and visceral organs such as kidneys, pancreas, and adrenal glands. It is therefore a multifaceted disease that requires multidisciplinary management.” This was stated by Alberto Feletti, associate professor of Neurosurgery, Department of Neuroscience, Biomedicine and Movement at the University of Verona, at the presentation of ‘Beyond the folds of rarity’, the new awareness campaign promoted by MSD with the patronage of the Italian Vhl Families Association Onlus, dedicated to von Hippel-Lindau syndrome.

“Early diagnosis is fundamental to include patients in an active clinical and radiological surveillance pathway, and to allow us to intervene before any symptoms or deficits become irreversible,” continued Feletti. “Today we have various diagnostic and therapeutic strategies, to which belzutifan, a new drug that is significantly changing the management of the disease, has recently been added. We hope that this therapy can improve the quality of life of patients, reducing the need for surgical interventions.”

“Information campaigns are also of utmost importance,” emphasized the expert. “They must raise patients’ awareness of the importance of surveillance and, at the same time, increase knowledge of the pathology among health professionals, thus facilitating early diagnosis.”

Jiji Press

Related

Page TOP